Advertisement

Efficacy of lycopene for management of oral potentially malignant disorders: A systematic review and meta-analysis

Published:August 20, 2022DOI:https://doi.org/10.1016/j.oooo.2022.08.004

      Objective

      The aim of this study was to investigate the available evidence on the efficacy of lycopene in the management of oral potentially malignant disorders (OPMDs).

      Study Design

      PubMed, Scopus, Web of Science, Google Scholar, China National Knowledge Infrastructure, and ProQuest databases were searched up to April 20, 2022. All clinical trials that assessed the efficacy of lycopene (I) on the signs/symptoms (O) of patients with OPMDs (P) in comparison to either active control or placebo (C) were included. Meta-analysis was conducted using the RevMan software (Cochrane Collaboration, London, UK).

      Results

      A total of 27 clinical trials (20 on oral submucosa fibrosis [OSF], 5 on oral lichen planus [OLP], and 2 on leukoplakia) were included. Overall, lycopene was efficacious in reducing signs and symptoms of OSF, OLP, and leukoplakia. The pooled data revealed comparable efficacy of lycopene and prednisolone in reducing pain and promoting clinical resolution of OLP. Additionally, the pooled data reported comparable efficacy of lycopene and conventional controls in improving the mouth opening and tongue protrusion in patients with OSF.

      Conclusions

      The results reveal promising effects of lycopene in alleviating signs and symptoms of OSF, OLP, and leukoplakia. However, owing to the observed heterogeneity and short follow-up periods, further well-designed studies with long-term therapy and follow-up are highly recommended.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Warnakulasuriya S
        • Kujan O
        • Aguirre-Urizar JM
        • et al.
        Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
        Oral Dis. 2021; 27: 1862-1880
        • Warnakulasuriya S
        • Johnson NW
        • van der Waal I.
        Nomenclature and classification of potentially malignant disorders of the oral mucosa.
        J Oral Pathol Med. 2007; 36: 575-580
        • Alaizari NA
        • Sperandio M
        • Odell EW
        • Peruzzo D
        • SA Al-Maweri
        Meta-analysis of the predictive value of DNA aneuploidy in malignant transformation of oral potentially malignant disorders.
        J Oral Pathol Med. 2018; 47: 97-103
        • Mello FW
        • Miguel AFP
        • Dutra KL
        • et al.
        Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis.
        J Oral Pathol Med. 2018; 47: 633-640
        • Iocca O
        • Sollecito TP
        • Alawi F
        • et al.
        Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype.
        Head Neck. 2020; 42: 539-555
        • Angadi PV.
        Little evidence that current interventions can benefit patients with OSMF.
        Evid Based Dent. 2011; 12: 43
        • Aziz SR.
        Lack of reliable evidence for oral submucous fibrosis treatments.
        Evid Based Dent. 2009; 10: 8-9
        • Lodi G
        • Porter S.
        Management of potentially malignant disorders: evidence and critique.
        J Oral Pathol Med. 2008; 37: 63-69
        • Warnakulasuriya S.
        Oral potentially malignant disorders: a comprehensive review on clinical aspects and management.
        Oral Oncol. 2020; 102104550
        • SA Al-Maweri
        Efficacy of curcumin for management of oral submucous fibrosis: a systematic review of randomized clinical trials.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 127: 300-308
        • Binnal A
        • Tadakamadla J
        • Rajesh G
        • Tadakamadla SK.
        Photodynamic therapy for oral potentially malignant disorders: a systematic review and meta-analysis.
        Photodyn Ther. 2022; 37102713
        • Ribeiro AS
        • Salles PR
        • da Silva TA
        • Mesquita RA.
        A review of the nonsurgical treatment of oral leukoplakia.
        Int J Dent. 2010; 2010186018
        • Al-Maweri SA
        • Ashraf S
        • Lingam AS
        • et al.
        Aloe vera in treatment of oral submucous fibrosis: a systematic review and meta-analysis.
        J Oral Pathol Med. 2019; 48: 99-107
        • de Pauli Paglioni M
        • Migliorati CA
        • Schausltz Pereira Faustino I
        • et al.
        Laser excision of oral leukoplakia: does it affect recurrence and malignant transformation? A systematic review and meta-analysis.
        Oral Oncol. 2020; 109104850
        • Guo J
        • Xie H
        • Wu H
        • Liang M.
        Efficacy of lycopene in the treatment of oral submucous fibrosis: a meta-analysis of randomized controlled trials.
        J Evid Based Dent Pract. 2020; 20101471
        • Kwatra B.
        A review on potential properties and therapeutic applications of lycopene.
        Int J Med Biomed Stud. 2020; 4: 33-44
        • Lu R
        • Dan H
        • Wu R
        • et al.
        Lycopene: features and potential significance in the oral cancer and precancerous lesions.
        J Oral Pathol Med. 2011; 40: 361-368
        • Cheng HC
        • Chien H
        • Liao CH
        • Yang YY
        • Huang SY.
        Carotenoids suppress proliferating cell nuclear antigen and cyclin D1 expression in oral carcinogenic models.
        J Nutr Biochem. 2007; 18: 667-675
        • El-Rouby DH.
        Histological and immunohistochemical evaluation of the chemopreventive role of lycopene in tongue carcinogenesis induced by 4-nitroquinoline-1-oxide.
        Arch Oral Biol. 2011; 56: 664-671
        • Gupta S
        • Jawanda MK
        • Arora V
        • Mehta N
        • Yadav V.
        Role of lycopene in preventing oral diseases as a nonsurgical aid of treatment.
        Int J Prev Med. 2015; 6: 70
        • Livny O
        • Kaplan I
        • Reifen R
        • Polak-Charcon S
        • Madar Z
        • Schwartz B.
        Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells.
        J Nutr. 2002; 132: 3754-3759
        • Arakeri G
        • Patil S
        • Maddur N
        • et al.
        Long-term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): a 3-years follow-up study.
        J Oral Pathol Med. 2020; 49: 803-808
        • Eita AAB
        • Zaki AM
        • Mahmoud SA.
        Serum 8-isoprostane levels in patients with resistant oral lichen planus before and after treatment with lycopene: a randomized clinical trial.
        BMC Oral Health. 2021; 21: 1-9
        • Kumar A
        • Bagewadi A
        • Keluskar V
        • Singh M.
        Efficacy of lycopene in the management of oral submucous fibrosis.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: 207-213
        • Nayak A
        • Anitha B
        • Bhattacharya A
        • Podder S.
        Efficacy of lycopene in combination with vitamin E in management of oral submucous fibrosis—a clinical prospective study.
        J Adv Med Dent Sci Res. 2015; 3: 21
        • Saawarn N
        • Shashikanth M
        • Saawarn S
        • Jirge V
        • Chaitanya NC
        • Pinakapani R.
        Lycopene in the management of oral lichen planus: a placebo-controlled study.
        Indian J Dent Res. 2011; 22: 639-643
        • Singh M
        • Bagewadi A.
        Comparison of effectiveness of Calendula officinalis extract gel with lycopene gel for treatment of tobacco-induced homogeneous leukoplakia: a randomized clinical trial.
        Int J Pharm Investig. 2017; 7: 88-93
        • Sunderraj S
        • Sharma R
        • Agarwal V
        • Narang P
        • Reddy YD
        • Sharma AK.
        An in vivo study to determine the efficacy of lycopene as compared to multivitamin preparation in the treatment of oral submucous fibrosis.
        J Indian Acad Oral Med Radiol. 2012; 24: 190-193
        • Gupta N
        • Kalaskar A
        • Kalaskar R.
        Efficacy of lycopene in management of oral submucous fibrosis- a systematic review and meta-analysis.
        J Oral Biol Craniofac Res. 2020; 10: 690-697
        • Page MJ
        • McKenzie JE
        • Bossuyt PM
        • et al.
        The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
        BMJ. 2021; 372: n71
        • Chole RH
        • Balsaraf V
        • Dangi B
        • et al.
        A randomized controlled trail of lycopene in oral submucous fibrosis.
        J Indian Assoc Public Health Dent. 2011; 3: 1156-1159
        • Goel S
        • Ahmed J.
        A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan.
        J Cancer Res Ther. 2015; 11: 113-118
        • Gupta A
        • Kumar S
        • Srivastava P
        • Rathi VC
        • Saxena S
        • Aggarwal A.
        Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study.
        J Oral Maxillofac Pathol. 2021; 25: 411-416
        • Johny J
        • Bhagvandas SC
        • Mohan SP
        • Punathil S
        • Moyin S
        • Bhaskaran MK.
        Comparison of efficacy of lycopene and lycopene–hyaluronidase combination in the treatment of oral submucous fibrosis.
        J Pharm Bioallied Sci. 2019; 11: S260-S264
        • Karemore TV
        • Motwani M.
        Evaluation of the effect of newer antioxidant lycopene in the treatment of oral submucous fibrosis.
        Indian J Dent Res. 2012; 23: 524-528
        • Kopuri RKC
        • Chakravarthy C
        • Sunder S
        • Patil RS
        • Shivaraj W
        • Arakeri G.
        A comparative study of the clinical efficacy of lycopene and curcumin in the treatment of oral submucous fibrosis using ultrasonography.
        J Int Oral Health. 2016; 8: 687-691
        • Patil S
        • Khandelwal S
        • Maheshwari S.
        Comparative efficacy of newer antioxidants spirulina and lycopene for the treatment of oral submucous fibrosis.
        Clin Cancer Investig J. 2014; 3: 482
        • Patil S
        • Sghaireen M
        • Maheshwari S
        • Kunsi S
        • Sahu R.
        Comparative study of the efficacy of lycopene and aloe vera in the treatment of oral submucous fibrosis.
        Int J Health Allied Sci. 2015; 4: 13-17
        • Patil SR
        • Yadav N
        • IA Al-Zoubi
        • et al.
        Comparative study of the efficacy of newer antioxitands lycopene and oxitard in the treatment of oral submucous fibrosis.
        Pesqui Bras Odontopediatria Clin Integr. 2018; 18: e4059
        • Piyush P
        • Mahajan A
        • Singh K
        • Ghosh S
        • Gupta S.
        Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial.
        Oral Dis. 2019; 25: 73-79
        • Rathod A
        • Deepa B.
        Effectiveness of various treatment modalities in the management of oral submucous fibrosis—a clinical study.
        J Adv Med Dent Sci Res. 2021; 9: 135-138
        • Samuel HT
        • Renukananda G.
        Comparative study between intralesional steroid injection and oral lycopene in the treatment of oral submucous fibrosis.
        Int J Sci Study. 2015; 2: 20-22
        • Singh D
        • Shashikanth MC
        • Misra N
        • Agrawal S.
        Lycopene and intralesional betamethasone injections in the management of oral submucous fibrosis.
        J Indian Acad Oral Med Radiol. 2014; 26: 264-268
        • Beenakumary TP
        • Gopinathan Anju
        • Varghese M
        • Raghavan R
        • Vm MN
        • Pius A
        Evaluation of therapeutic efficacy of different treatment modalities in oral submucous fibrosis: a comparative study.
        J Contemp Dent Pract. 2019; 20: 390-394
        • Arshad O
        • Mahmood Siddiqi K
        • Ahmad Rana Z
        Oral submucous fibrosis: comparison of different treatment modalities.
        Pakistan Oral Dent J. 2015; 35: 364-369
        • Subramaniam AV
        • Subramaniam T
        • Agarwal N.
        Assessment of the effectiveness of antioxidant therapy (lycopene) and therapeutic ultrasound in the treatment of oral submucous fibrosis.
        Int J Pharm Therapeut. 2014; 5: 344-350
        • Hazzaa HH
        • Elsaadany B
        • Abdulhady EM
        • Ahmed EM.
        Lycopene versus corticosteroid in the treatment of symptomatic oral lichen planus patients: a randomized double blinded clinical trial.
        Dent Craniofac Res. 2021; 6: 1-7
        • Kushwaha RP
        • Rauniar GP
        • Rimal J.
        Comparative study of the efficacy of lycopene versus prednisolone in the management of oral lichen planus—a randomized, double blind clinical trial.
        World J Pharm Pharm Sci. 2017; 6: 1103-1115
        • Shekhawat K
        • Deepak T
        • Srivastava C.
        Assessment of lycopene and levamisole in management of oral lichen planus—a comparative study.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 2: 4-10
        • Singh M
        • Krishanappa R
        • Bagewadi A
        • Keluskar V.
        Efficacy of oral lycopene in the treatment of oral leukoplakia.
        Oral Oncol. 2004; 40: 591-596
        • Campos KKD
        • Araújo GR
        • Martins TL
        • et al.
        The antioxidant and anti-inflammatory properties of lycopene in mice lungs exposed to cigarette smoke.
        J Nutr Biochem. 2017; 48: 9-20
        • Palozza P
        • Simone R
        • Catalano A
        • et al.
        Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression.
        J Nutr Biochem. 2011; 22: 259-268
        • Palozza P
        • Simone RE
        • Catalano A
        • et al.
        Modulation of MMP-9 pathway by lycopene in macrophages and fibroblasts exposed to cigarette smoke.
        Inflamm Allergy Drug Targets. 2012; 11: 36-47
        • Moia VM
        • Leal Portilho F
        • Almeida Pádua T
        • et al.
        Lycopene used as anti-inflammatory nanodrug for the treatment of rheumathoid arthritis: animal assay, pharmacokinetics, ABC transporter and tissue deposition.
        Colloids Surf B Biointerfaces. 2020; 188110814
        • Zhang FF
        • Morioka N
        • Kitamura T
        • et al.
        Lycopene ameliorates neuropathic pain by upregulating spinal astrocytic connexin 43 expression.
        Life Sci. 2016; 155: 116-122
        • Guo JC
        • Xie H
        • Wu H
        • Liang MN.
        Efficacy of lycopene in the treatment of oral submucous fibrosis: a meta-analysis of randomized controlled trials.
        J Evid Based Dent Pract. 2020; 20101471
        • Wang R
        • Lu X
        • Yu R.
        Lycopene inhibits epithelial-mesenchymal transition and promotes apoptosis in oral cancer via PI3K/AKT/m-TOR signal pathway.
        Drug Des Devel Ther. 2020; 14: 2461-2471
        • Stahl W
        • Sies H.
        Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans.
        J Nutr. 1992; 122: 2161-2166